There's a difference of disagreeing and backing that up with facts, vs someone disagreeing simply because yhey hold stock in a company operating in the same space.
You have pointed to Cynata missing a deadline on when they expected for the aGvHD results to be ready - I think. Shocker, a missed timeline. Fact. Tell me other biotech companies that haven't, especially when trying to recruit patients in an Orphan indication.
Or were you referring to DFU? The CR? Either way, who gives a damn other than your pal Temu Pledge. It is obvious how much you know about this space, clearly, you got lucky after years of waiting backing your horse. Well done. Clearly you didn't sell your shares at $3.37 plus, hence you are still here. Well done. All that wisdom, knowledge, and now riding your SP back down. Hopefully at least you averaged down properly as we all know (and can be verified by your posts) when you started buying. Tell us, teach us, until the only green thing you may have left is your thumb.
If only we could discuss CYP with you over here. Sadly, we can't. You don't know the horse you backed, and have shown that you know even less about this stock you don't hold. But hey, keep polishing your ego while you can as that what it is all about. There will never be anything of value coming from your posts, on either stock.
Placebo controlled trial. Lets see how that goes. The trial being conducted by a third party is definitely a good thing, don't you think? Less room for recruitment one may consider selective (Galipeau and even the FDA reviewer - neither of them is on HC, therefore, please take their opinions with a grain of salt, or two).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)